Effects of the nitric oxide/cGMP system compared with the cAMP system on airway mucus secretion in the rat

被引:10
作者
Bredenbröker, D [1 ]
Dyarmand, D [1 ]
Meingast, U [1 ]
Fehmann, HC [1 ]
Staats, P [1 ]
Von Wichert, P [1 ]
Wagner, U [1 ]
机构
[1] Univ Marburg, Med Poliklin, Dept Internal Med, D-35043 Marburg, Germany
关键词
mucus secretion; nitric oxide (NO); cyclic nucleotide; second messenger; trachea; rat;
D O I
10.1016/S0014-2999(00)00918-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mucus secretion of the airways is under the control of a variety of intracellular second messenger systems. Cyclic nucleotides such as cGMP, coupled to the recently discovered nitric oxide system, and cAMP are of outstanding interest in this respect. The present study used the modified Ussing chamber technique and mucins labelled with (SO4)-S-35 to investigate mucus secretion in the rat trachea to clarify the contribution of these different second messenger systems to the control of mucin secretion. A variety of drugs affecting tither the generation or the breakdown of the respective cyclic nucleotides were used. Neither drugs interfering with nitric oxide synthase nor the phosphodiesterase isoenzyme responsible for cGMP breakdown nor cGMP analogues were able to affect mucus secretion. In contrast, stimulation of adenylate cyclase or inhibition of the respective phosphodiesterase resulted in a potent increase of mucus secretion. In conclusion. we failed to show the involvement of the nitric oxide/cGMP system. whereas the cAMP system seems to be a very efficient regulator of mucus secretion in the rot trachea. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:319 / 325
页数:7
相关论文
共 32 条
[21]   INHALED NITRIC-OXIDE AS A CAUSE OF SELECTIVE PULMONARY VASODILATATION IN PULMONARY-HYPERTENSION [J].
PEPKEZABA, J ;
HIGENBOTTAM, TW ;
DINHXUAN, AT ;
STONE, D ;
WALLWORK, J .
LANCET, 1991, 338 (8776) :1173-1174
[22]   NONADRENERGIC, NONCHOLINERGIC NEURAL CONTROL OF MUCUS SECRETION IN THE AIRWAYS [J].
RAMNARINE, SI ;
ROGERS, DF .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1994, 7 (01) :19-33
[23]   Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro [J].
Ramnarine, SI ;
Khawaja, AM ;
Barnes, PJ ;
Rogers, DF .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (04) :998-1002
[24]   EXPRESSION OF INDUCIBLE NITRIC-OXIDE IN HUMAN LUNG EPITHELIAL-CELLS [J].
ROBBINS, RA ;
BARNES, PJ ;
SPRINGALL, DR ;
WARREN, JB ;
KWON, OJ ;
BUTTERY, LDK ;
WILSON, AJ ;
GELLER, DA ;
POLAK, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) :209-218
[25]   Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein-coupled receptors [J].
Ulrich, CD ;
Holtmann, M ;
Miller, LJ .
GASTROENTEROLOGY, 1998, 114 (02) :382-397
[26]   Association of chronic mucus hypersecretion with FEV(1) decline and chronic obstructive pulmonary disease morbidity [J].
Vestbo, J ;
Prescott, E ;
Lange, P ;
Jensen, G ;
Schnohr, P ;
Appleyard, M ;
Nyboe, J ;
Gronbaek, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (05) :1530-1535
[27]   Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea [J].
Wagner, U ;
Bredenbroker, D ;
Storm, B ;
Tackenberg, B ;
Fehmann, HC ;
Von Wichert, P .
PEPTIDES, 1998, 19 (02) :241-245
[28]   GALANIN AND SOMATOSTATIN INHIBITION OF SUBSTANCE-P-INDUCED AIRWAY MUCUS SECRETION IN THE RAT [J].
WAGNER, U ;
FEHMANN, HC ;
BREDENBROKER, D ;
YU, F ;
BARTH, PJ ;
VONWICHERT, P .
NEUROPEPTIDES, 1995, 28 (01) :59-64
[29]   CONTROL OF MUCUS SECRETION IN AIRWAYS [J].
WAGNER, U ;
VONWICHERT, P .
RESPIRATION, 1991, 58 (01) :1-8
[30]   AMYLIN IMMUNOREACTIVITY IN THE RAT TRACHEA AND CHARACTERIZATION OF THE INTERACTION OF AMYLIN AND SOMATOSTATIN ON AIRWAY MUCUS SECRETION [J].
WAGNER, U ;
BREDENBROKER, D ;
BARTH, PJ ;
FEHMANN, HC ;
VONWICHERT, P .
RESEARCH IN EXPERIMENTAL MEDICINE, 1995, 195 (05) :289-296